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We identified, by homozygosity mapping, a novel locus on 10q21.3-q22.1 for Goldberg-Shprintzen syndrome
(GOSHS) in a consanguineous Moroccan family. Phenotypic features of GOSHS in this inbred family included
microcephaly and mental retardation, which are both central nervous system defects, as well as Hirschsprung
disease, an enteric nervous system defect. Furthermore, since bilateral generalized polymicogyria was diagnosed in
all patients in this family, this feature might also be considered a key feature of the syndrome. We demonstrate
that homozygous nonsense mutations in KIAA1279 at 10q22.1, encoding a protein with two tetratrico peptide
repeats, underlie this syndromic form of Hirschsprung disease and generalized polymicrogyria, establishing the
importance of KIAA1279 in both enteric and central nervous system development.
Goldberg-Shprintzen syndrome (GOSHS) (Goldberg
and Shprintzen 1981) is a disorder characterized by mi-
crocephaly, mental retardation, facial dysmorphism, and
Hirschsprung disease (HSCR). GOSHS shares the same
accession number (MIM 235730) in the Online Men-
delian Inheritance in Man (OMIM) database as the com-
parable disorder Mowat-Wilson syndrome (MWS) (Mo-
wat et al. 1998). Genetically, however, they are different.
MWS occurs as a de novo dominant syndrome, whereas
GOSHS is most likely inherited as an autosomal recessive
trait, a hypothesis based on the occurrence of the dis-
ease in consanguineous pedigrees and in affected siblings
with unaffected parents (Hurst et al. 1988; Brooks et al.
1999). MWS is associated with de novo mutations in
ZFHX1B, located at 2q22 (Amiel et al. 2001; Wakamat-
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su et al. 2001; Zweier et al. 2002), whereas, for GOSHS,
no causative gene has yet been identified. Also, some
clinical differences exist. In patients with MWS, neu-
rological abnormalities such as epilepsy (in a high per-
centage of patients), agenesis of the corpus callosum (in
35% of patients), and cortical malformations (in a mi-
nority of patients) have been reported (Amiel et al. 2001;
Zweier et al. 2002; Silengo et al. 2004). In the few pa-
tients with GOSHS discussed in published reports, neu-
rological symptoms have not been studied in detail, and
the cause of the microcephaly and mental retardation
remains obscure (Goldberg and Shprintzen 1981; Hurst
et al. 1988).
Here, we describe a family with HSCR (an anomaly
of the enteric nervous system that is of neural crest origin
and is histologically characterized by the absence of gan-
glion cells in the myenteric and submucosal plexuses)
(Okamoto and Ueda 1967) as a variable feature and bi-
lateral generalized polymicrogyria (PMG) (a develop-
mental malformation of the cerebral cortex, character-
ized by an enlarged number of smaller convolutions or
gyri and disruption of the normal six-layered cerebral
cortical structure) (Friede 1989) as a constant feature.
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Figure 1 Pedigree structure and haplotypes of the Moroccan family with GOSHS. Patients are represented as blackened symbols. The
shared region of homozygosity (red) in all affected cases is delimited by markers CGR166 and CGR170. Six of the 11 markers typed for refining
the candidate region between marker D10S1652 and D10S537 are shown.
The established diagnosis for this family was GOSHS,
although bilateral generalized PMG (BGP) has not been
reported as part of the syndrome before.
To unravel the genetic basis of GOSHS, we performed
a complete genome scan and homozygosity mapping in
a large consanguineous Moroccan family reported else-
where (Brooks et al. 1999). The segregation of the dis-
ease in the pedigree is consistent with an autosomal re-
cessive mode of inheritance, with several consanguine-
ous loops (fig. 1), and the family therefore was consid-
ered suitable for homozygosity mapping (Lander and
Botstein 1987). Informed consent was obtained from
the parents of all subjects. In this family, five patients
had the cardinal signs characterizing GOSHS (one boy
lacked HSCR). One child with long-segment HSCR died
in the neonatal period; his DNA was unavailable for our
study. When the youngest patient was diagnosed, brain
magnetic resonance imaging (MRI) revealed BGP. MRI
scans of all living patients also revealed BGP (fig. 2).
Gait disturbance, speech defect, excessive drooling, and
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Figure 2 Representative MRIs of patient VI-1 (panels A and B)
and patient VI-10 (panels C and D), showing BGP. A, Axial T2-
weighted MRI of patient VI-1 at age 5 mo, showing frontoparietal
and occipital bilateral PMG. B, Coronal FLAIR image of the same
patient showing perisylvian PMG (arrow). C, T1-weighted axial image
of patient VI-10 at age 14 years, showing BGP with distribution similar
to that seen in patient VI-1. D, Parasagittal T1-weighted image of
patient VI-10, showing PMG of the right peri-insular temporal lobe.
Table 1
Results of Two-Point LOD Score Analysis, Performed for Markers
Used in Fine Mapping
MARKERa
LOD AT v p
0 .01 .05 .1 .2 .3 .4
D10S196 13.81 3.96 1.52 .65 .08 .02 0
D10S1652 6.96 2.39 1.85 1.36 .68 .35 .15
D10S1743 4.97 1 1.39 1.31 .9 .46 .14
CGR166 3.7 .58 1.03 1.02 .73 .4 .13
CGR167 3.29b 3.21 2.9 2.51 1.73 1 .4
D10S210 2.59 2.53 2.26 1.92 1.26 .67 .24
D10S1678 1.49 1.45 1.29 1.09 .72 .4 .16
D10S1647 1.84 1.79 1.58 1.33 .86 .47 .19
D10S1672 2.88 2.81 2.52 2.15 1.42 .76 .25
D10S1665 2.77 2.7 2.43 2.08 1.39 .75 .25
CGR172 1.36 1.32 1.17 .97 .62 .32 .11
CGR170 .28 1.59 1.97 1.88 1.4 .83 .33
D10S676 .28 1.25 1.64 1.56 1.1 .59 .18
D10S537 .11 1.45 1.82 1.71 1.2 .65 .21
a Marker order follows that of the Celera physical map.
b Max LOD score.
pseudobulbar signs indicate diffuse cortical dysfunction
including the perisylvian areas.
Genomic DNA was isolated from peripheral leuko-
cytes by use of the method described by Miller et al.
(1988). By haplotyping, FISH, and sequence analyses,
we excluded the ZFHX1B gene as a cause of GOSHS
in this family (data not shown). For the systematic ge-
nome scan, 381 markers (STRPs) from the ABI Prism
Linkage Mapping Set MD-10 (version 2.5), with an av-
erage spacing of 10 cM, were tested. DNA amplification
was performed using 25 ng genomic DNA in 7.5-ml
PCRs containing 1# PCR Gold Buffer, 2.5 mM MgCl2,
10 mM primer pair mix, and 0.4 U AmpliTaq Gold DNA
polymerase (Applied Biosystems). Amplification condi-
tions were 10 min at 95C, followed by 35 cycles of 30
s at 95C, 30 s at 55C, and 1 min 30 s at 72C; am-
plification was ended by a final extension for 5 min at
72C. PCR products were pooled in panels and were
loaded on an ABI 3100 automated sequencer. Data were
analyzed using GeneMapper software (version 2.1) (Ap-
plied Biosystems).
After this initial screening, a region on 10q21.3-q22.1
was further investigated, since one of the four affected
individuals was homozygous by descent for two con-
secutive markers, D10S1652 and D10S537, whereas the
other three patients were homozygous for one of these
two markers. No other regions of homozygosity for con-
secutive markers were identified. We saturated the region
between markers D10S1652 and D10S537 (12.3 cM)
with 11 additional markers; they either were obtained
from the Marshfield genetic map (Center for Medical
Genetics Web site) or were newly developed. Marker
order and genetic distances were obtained from the
Marshfield genetic map (Center for Medical Genetics
Web site) and the Celera physical map. All patients were
homozygous for 7 of these 11 markers. A recombination
event between loci CGR166 and CGR167 in patient VI-
7 defined the centromeric boundary of the genetic in-
terval. The telomeric border was defined by recombi-
nation events between markers D10S1665 and CGR170
in patients VI-1 and VI-3 (fig. 1). These recombination
events reduced the candidate region to a minimum of
2.8 Mb and a maximum of 3.8 Mb.
Parametric two-point and multipoint linkage analyses
were performed using the MLINK program from the
LINKAGE (version 5.1) software package (Lathrop and
Lalouel 1984) and the SimWalk2 program (version 2.9)
(Sobel et al. 2002). LOD scores were calculated, under
the assumption that the disease phenotype is a rare au-
tosomal recessive disorder with 100% penetrance, with
a gene frequency of 1:5,000. No phenocopies were al-
lowed, and equal allele frequencies were used because
of the limited number of available independent family
members. A significant two-point LOD score was ob-
tained (max LOD score 3.29 and for markervp 0
CGR167) (table 1), which increased to a maximum mul-
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Figure 3 Multipoint LOD score analysis across and beyond the
region of homozygosity, flanked by markers D10S1652 and CGR170,
with a peak LOD score of 5.9.
Table 2
Gene and Marker Positions and Details
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 4 Mutations of KIAA1279 associated with GOSHS. A,
Electropherogram of the mutation identified in the Moroccan family.
The 303CrT mutation causes the replacement of an arginine with a
stop codon (R90X) in exon 1. B, Electropherogram of the mutation
identified in the Pakistani family. A homozygous GrT transversion at
nt 285 results in the replacement of a glutamic acid with a stop codon
(E84X) in the patients.
tipoint LOD score of 5.9 between markers CGR167 and
D10S1647 (fig. 3).
The maximum 3.8-Mb linked region of shared ho-
mozygosity (defined by CGR166 and CGR170) con-
tained a total of 25 known genes and 5 genes encoding
hypothetical proteins, in accordance with the National
Center for Biotechnology Information (NCBI) build 34
of the human genome and the Ensembl Genome Browser
(table 2). We first sequenced seven functional candidate
genes on the basis of their putative involvement in neu-
rogenesis (CTNNA3, LRRTM3, ATOH7, DDX50,
DDX21, NET-7, and NEUROG3), either using cDNA
obtained by RT-PCR from a lymphoblastoid cell line of
patient VI-10 and from a control or using genomic DNA
from both. Mutations were not identified. We then per-
formed a systematic mutational screening of all tran-
scripts from the candidate region. PCR products from
either genomic DNA (exons including flanking intronic
sequences) or reverse-transcribed products (ORFs) were
amplified and purified (ExoSapIT [USB]). PCR primers,
which were designed using standard software (Primer3),
and conditions are available on request. Bidirectional se-
quencing was performed using BigDye Terminator chem-
istry on an ABI 3100 sequencer (Applied Biosystems).
With the use of the software package SeqScape (version
2.1) (Applied Biosystems), sequences were aligned and
compared with consensus sequences.
Analysis of 98% of all coding sequences from the
region revealed one likely disease-causing homozygous
nucleotide substitution, 303CrT, in exon 1 of the
KIAA1279 gene (fig. 4A). This transversion leads, at the
amino acid level, to the replacement of an arginine with
a stop codon (R90X), resulting in a shortened protein
of 89 aa. The 303CrT mutation showed complete seg-
regation with the disease in the family. One hundred
ethnically matched control chromosomes (of North Af-
rican origin) were screened for the R90X mutation, and
none of the controls carried this mutation. Subsequently,
one additional family of British Pakistani ancestry, with
a phenotype similar to that found in the Moroccan fam-
ily, was screened for mutations in this gene. This family
had four affected individuals with multiple inbreed-
ing loops. Clinical characteristics were consistent with
GOSHS, and CT brain scans of this family were de-
scribed in a previous study (Hurst et al. 1988) and were
thought to represent an abnormality of neuronal migra-
tion. In the affected individuals, a homozygous GrT
transversion was identified at nt 285, resulting, at the
amino acid level, in the replacement of a glutamic acid
with a stop codon (E84X) (fig. 4B). Two different ho-
mozygous nonsense mutations in KIAA1279 in two in-
dependent families with GOSHS strongly indicate that
KIAA1279 is the gene responsible for GOSHS.
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Figure 5 Expression of KIAA1279 in human adult and fetal tissues. A, Multitissue northern blots, incubated with a KIAA1279 probe,
showing ubiquitous expression without a specific pattern (note the lack of expression in blood leukocytes). B, Northern blots from adult brain
tissues, incubated with a KIAA1279 probe. C, Human fetal multitissue northern blot, showing widespread expression.
KIAA1279 consists of seven exons spanning 28 kb of
genomic DNA. The transcript encodes a protein of 621
aa. We identified orthologs of human KIAA1279 in fruit
fly, frog, rat, mouse, bee, chicken, and Japanese puffer
fish, using BLAST comparison (NCBI Web site). There is
strong sequence conservation during evolution; the pro-
tein sequence of human KIAA1279 shares 89% amino
acid identity with mouse product, 88% with rat product,
and 29% with fruit fly product. Multitissue northern blots
(both adult and fetal) (fig. 5) showed ubiquitous expres-
sion of the 2.4-kb KIAA1279 mRNA without a specific
pattern, with expression lacking only in blood leukocytes
(fig. 5A). In addition, northern blot hybridization iden-
tified KIAA1279 mRNA molecules in different parts of
the adult CNS—namely, cerebellum, cortex, medulla, spi-
nal cord, occipital lobe, frontal lobe, temporal lobe, and
putamen (fig. 5B). This widespread KIAA1279 expression
is consistent with data available in gene expression da-
tabases such as the Gene Expression Omnibus, the Hu-
man Unidentified Gene-Encoded (HUGE) Protein Data-
base, and the University of California–Santa Cruz (UCSC)
Genome Browser. The function of KIAA1279 is un-
known. Neither the gene nor its derived protein shows
any significant sequence similarity to known human
Reports 125
cDNA or protein sequences. Possible aspects of the mo-
lecular function of KIAA1279 may be gleaned from its
primary sequence. We predicted protein motifs and do-
mains using the program SMART (Simple Modular Ar-
chitecture Research Tool). The predicted protein contains
two tetratrico peptide repeats (TPRs), which are struc-
tural motifs consisting of 34 amino acid residues, in exon
1/2 and exon 4, respectively. Because of these repeats,
KIAA1279 may be considered a member of the TPR
protein family (D’Andrea and Regan 2003). The most
basic function of TPR motifs is to mediate protein-pro-
tein interactions. Proteins with TPR motifs are involved
in a variety of biological processes, such as cell-cycle reg-
ulation, transcriptional control, mitochondrial and per-
oxisomal protein transport, neurogenesis, and protein
folding. Several diseases have been described as being
caused by mutations in genes encoding proteins con-
taining TPR domains—for example, Leber congenital
amaurosis (AIPL1) (Sohocki et al. 2000) and Charcot-
Marie-Tooth type 4C neuropathy (KIAA1985) (Sender-
ek et al. 2003).
Since mutations in KIAA1279 are associated with
HSCR and PMG, its protein product may play a pivotal
role in both peripheral and central nervous system de-
velopment. PMG is traditionally classified as a result of
a disruption such as fetal hypoxic ischemic damage, in-
fection, or exposure to toxic drugs in the second tri-
mester (13–21 wk) (Barth and van der Harten 1985;
Barth 2003). However, the identification of KIAA1279
as the GOSHS gene underlines the importance of genetic
factors in the etiology of this neuronal migration dis-
order of the cortex, as was already proven (Mitchell et
al. 2003; Piao et al. 2004) or suggested (Ciardo et al.
2001; Chang et al. 2004) for other forms of PMG. Under
the assumption that the main function of KIAA1279 is
to bind other proteins, these target peptides might be
(known) HSCR- or PMG-associated susceptibility fac-
tors. More likely, however, these targets might play a
more general role in neuronal development, since a mal-
formation of cortical organization is a constant feature
found in the Moroccan family, whereas HSCR is a var-
iable feature. Elucidation of KIAA1279 function and,
more important, studies of KIAA1279 expression and
protein interactions may provide new insight into the
molecular basis of PMG and HSCR.
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